BR Form 4: Director Nazareth Awarded 17,047 Dividend-Linked Stock Units

Rhea-AI Filing Summary

Annette L. Nazareth, a Director of Broadridge Financial Solutions, Inc. (BR), reported two grants of Deferred Stock Units on 10/02/2025 under the company’s 2018 Omnibus Award Plan tied to the regular quarterly dividend. The filings show awards of 8,519 and 8,528 Deferred Stock Units, each representing a like number of common shares and recorded with a $0.0000 per-share price. The Deferred Stock Units vest in full upon grant and are payable in shares when the director separates from service. The form was signed under power of attorney on 10/03/2025.

Positive

• 17,047 Deferred Stock Units awarded, increasing reported beneficial ownership
• Awards vest in full upon grant, ensuring the director’s entitlement is not contingent on future service

Negative

• None.

Insights

Corporate Governance Expert

Routine dividend-related director awards increased reported beneficial ownership by 17,047 stock units.

The Form 4 documents awards of 8,519 and 8,528 Deferred Stock Units dated 10/02/2025, given in connection with Broadridge’s regular quarterly dividend and issued under the 2018 Omnibus Award Plan. These DCUs vest immediately and convert to common stock upon the director’s separation from service, so the grants increase reported beneficial holdings though they are subject to settlement timing.

The filing was executed via power of attorney on 10/03/2025, which is a standard administrative step for insider reporting.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Nazareth Annette L.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	10	$0.00	--
Grant/Award	Common Stock	9	$0.00	--

Holdings After Transaction: Common Stock — 8,519 shares (Direct)

Footnotes (1)

1. The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Nazareth Annette L.

(Last) (First) (Middle)

5 DAKOTA DRIVE

(Street)

LAKE SUCCESS NY 11042

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BROADRIDGE FINANCIAL SOLUTIONS, INC. [ BR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/02/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/02/2025		A		10(1)	A	$0.0000	8,519	D
Common Stock	10/02/2025		A		9(2)	A	$0.0000	8,528	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

2. The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

	Maria Allen, Power of Attorney	10/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who filed the Form 4 for Broadridge (BR)?

The reporting person is Annette L. Nazareth, identified as a Director of Broadridge.

What securities were reported on the Form 4 dated 10/02/2025 for BR?

Two grants of Deferred Stock Units under the 2018 Omnibus Award Plan: 8,519 and 8,528 units, tied to the quarterly dividend.

When will the Deferred Stock Units settle into Broadridge common stock?

The DCUs vest in full upon grant and will settle in shares of Broadridge common stock upon the director’s separation from service.

Was there a cash price paid for these awards?

The reported price per unit is shown as $0.0000 in the Form 4 entries.

Was the Form 4 signed and when?

The Form 4 shows execution via power of attorney by Maria Allen on 10/03/2025.